President, Representative Director Terukazu Kato PLAY LIST from the beginning Second Quarter Business Results for Fiscal 2018 (From April 1, 2018 to September 30, 2018) Roadmap to Realizing Long-Term Vision Long-Term Business Vision Second Quarter Business Results for Fiscal 2018 2Q Consolidated Performance for Fiscal 2018 Key Points in Performance Factors in Increase / Decrease of Operating Profit Financial Condition / Cash Flow Position Initiatives for & Progress in Tackling Strategic Issues Sales performance of prescription Kampo products Long-Term Business Vision Supporting Education Related to KampoMedicine for Doctors Method of Approaching Doctors that Write 10 or More KampoPrescriptions Annual Sales of Prescription Kampo Products (All markets/NHI price base) Three Important Domains and Key Sales Measures Analysis of Sales Catalysts (Rikkunshito) Prescription Intention among Doctors & Achievement Rate (Rikkunshito) Measures related to Rikkunshito Measures related to Daikenchuto Kampo BPSD Network Gynecology field: Hold Gynecological Kampo Medication Seminar, etc. 2H Key Measures Expansion of Cultivated Land under Own management area Progress in China Business - Ping An Tsumura -(1) Progress in China Business - Ping An Tsumura -(2) Progress in China Business - Ping An Tsumura Analytical Research Center - Topics for ESG Activities Domestic crude drug cultivation measures Integrated Report 2018 FY2018 Performance Forecasts(1) FY2018 Performance Forecasts(2) Return of Profits to Shareholders Return of Profits to Shareholders @ Back Next